The PredictPlusPrevent Study
Universal Prevention of Depression and Anxiety in the General Population Through a Personalized Intervention Based on Risk Algorithms, ICTs, and Decision Support Systems: Randomized Controlled Trial. The PredictPlusPrevent Study
Sponsor: The Mediterranean Institute for the Advance of Biotechnology and Health Research
Listed as NCT06351800, this NA trial focuses on Anxiety Disorders and Depression and remains actively recruiting participants. Sponsored by The Mediterranean Institute for the Advance of Biotechnology and Health Research, it has been updated 4 times since 2026, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
4 versions recorded-
Oct 2025 — Present [monthly]
Not Yet Recruiting NA
-
Sep 2024 — Oct 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The Mediterranean Institute for the Advance of Biotechnology and Health Research
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.